BioSpace News Archive

Today, Celgene submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its ozanimod for adults with relapsing forms of multiple sclerosis (RMS).

Hans Bishop’s Sana Biotechnology, which launched earlier this year, inked a deal with Harvard University for a foundational technology that will protect transplanted cells from immune attack.

Numerous top biopharma executives met recently in Manalapan, Florida for the R&D Leadership Summit. Although a wide range of topics were discussed, certain areas rose to the top as being of particular concern to industry leadership. Here’s a look at a few of those concerns.

Embattled Purdue Pharma has agreed to pay $270 million to settle a lawsuit brought against the company over the marketing of its opioid painkiller OxyContin, according to reports.

YL Biolologics Ltd., Yoshindo Inc. and Teijin Ltd. have announced that on March 26, 2019, YL Biologics obtained manufacturing and sales approval for Etanercept biosimilar, an agent for anti-rheumatoid arthritis and polyarticular-course juvenile idiopathic arthritis which YL Biologics has developed globally.

The shareholders of Immunicum AB, reg. no 556629-1786, are hereby invited to the Annual General Meeting on Thursday, 25 April 2019, at 10:30, at Sturegatan 15’s premises, at Sturegatan 15, SE-161 14 36 Stockholm.

LNC Therapeutics intends to develop a new class of drugs based on christensenella for the treatment of obesity, metabolic diseases, and other serious indications with significant unmet medical needs

First Latin American Approval of Crysvita, the only Treatment that Targets the Underlying Cause of this Rare, Hereditary, Lifelong Disease

The world-renowned HGH Infrared Systems is developing its brand image and communication strategy to better reflect its position as a global leader in the optronics market.

Evotec and the mark foundation form first collaboration together to advance oncology assets based on evotec’s new allosteric inhibitor platform “Targetallomod”